PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 148 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |